Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin and Retinal Amyloid-beta Pilot Study
NCT05774704Phase 2Recruiting
- Sponsor
- Texas Tech University Health Sciences Center
- Start
- Aug 2023
- Primary completion
- Dec 2026
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of curcumin in Alzheimer's disease (AD), amyloidosis, sponsored by Texas Tech University Health Sciences Center. Started Aug 2023; status: recruiting.
02
Drugs
curcumin
03
Conditions
Alzheimer's disease (AD)amyloidosis
Beyond the preview
Go deeper on NCT05774704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05774704.